JP2019535311A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535311A5 JP2019535311A5 JP2019545700A JP2019545700A JP2019535311A5 JP 2019535311 A5 JP2019535311 A5 JP 2019535311A5 JP 2019545700 A JP2019545700 A JP 2019545700A JP 2019545700 A JP2019545700 A JP 2019545700A JP 2019535311 A5 JP2019535311 A5 JP 2019535311A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- item
- scpv
- viral genome
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022140113A JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662416577P | 2016-11-02 | 2016-11-02 | |
| US62/416,577 | 2016-11-02 | ||
| US201662434794P | 2016-12-15 | 2016-12-15 | |
| US62/434,794 | 2016-12-15 | ||
| PCT/US2017/059782 WO2018085582A1 (en) | 2016-11-02 | 2017-11-02 | Synthetic chimeric poxviruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140113A Division JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019535311A JP2019535311A (ja) | 2019-12-12 |
| JP2019535311A5 true JP2019535311A5 (enExample) | 2020-12-10 |
Family
ID=62075555
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545700A Pending JP2019535311A (ja) | 2016-11-02 | 2017-11-02 | 合成キメラポックスウイルス |
| JP2022140113A Withdrawn JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A Pending JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140113A Withdrawn JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A Pending JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US11345896B2 (enExample) |
| EP (1) | EP3535389A4 (enExample) |
| JP (3) | JP2019535311A (enExample) |
| CN (1) | CN110431228B (enExample) |
| AU (2) | AU2017353868C1 (enExample) |
| CA (1) | CA3042694A1 (enExample) |
| IL (2) | IL319942A (enExample) |
| MX (1) | MX2019005102A (enExample) |
| SG (1) | SG11201903893PA (enExample) |
| TW (2) | TWI887191B (enExample) |
| WO (1) | WO2018085582A1 (enExample) |
| ZA (3) | ZA201902868B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL319942A (en) | 2016-11-02 | 2025-05-01 | Evans David | Synthetic chimeric poxviruses, methods for their production, compositions containing them and uses thereof |
| WO2018148710A1 (en) * | 2017-02-13 | 2018-08-16 | Excision Biotherapeutics, Inc. | Visualizing viral reservoirs and dissemination in vivo |
| CA3099330A1 (en) * | 2018-05-02 | 2019-11-07 | Tonix Pharma Holdings Limited | Synthetic chimeric vaccinia virus |
| US20240024393A1 (en) * | 2019-01-25 | 2024-01-25 | Virocure, Inc. | Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus |
| US20230097513A1 (en) * | 2020-02-03 | 2023-03-30 | City Of Hope | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof |
| BR112022016992A2 (pt) * | 2020-02-26 | 2022-10-25 | Tonix Pharma Ltd | Vacina com base em poxvírus recombinante contra ví-rus sars-cov-2 |
| EP4153228A4 (en) | 2020-05-17 | 2024-07-10 | City of Hope | CORONAVIRUS VACCINES BASED ON SYNTHETIC MODIFIED ANKARA VACCINE (SMVA) VIRUS |
| BR112023015467A2 (pt) | 2021-02-02 | 2023-10-10 | Geovax Inc | Vetor viral de vaccinia ankara recombinante modificado, métodos para aumentar uma resposta imunológica a um antígeno alvo em um paciente e para prevenir, tratar ou induzir uma resposta imunológica contra um antígeno alvo, e, composição farmacêutica |
| WO2023168286A1 (en) | 2022-03-01 | 2023-09-07 | Tonix Pharmaceuticals Holding Corp. | Recombinant poxvirus based vaccine against the omicron strain of sars-cov-2 virus and variants thereof |
| CN117264909B (zh) * | 2023-10-25 | 2024-11-26 | 深圳湾实验室 | 反式互补缺陷猴痘病毒及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2787577A (en) | 1953-12-01 | 1957-04-02 | Lilly Co Eli | Stable smallpox vaccine |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US6723325B1 (en) | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
| CA2431349A1 (en) * | 2002-06-06 | 2003-12-06 | Xiao-Dan Yao | Method of producing a recombinant virus |
| EP1678292A4 (en) | 2003-09-18 | 2008-05-07 | Univ Emory | IMPROVED MVA VACCINES |
| WO2006022215A1 (ja) | 2004-08-23 | 2006-03-02 | The Japan Health Sciences Foundation | SARS-コロナウイルスタンパク質をコードするDNAを保有する組換えワクチニアウイルスDIs株、およびその利用 |
| CN101020055B (zh) | 2006-02-16 | 2012-08-08 | 中国疾病预防控制中心性病艾滋病预防控制中心 | 基于复制型痘苗病毒载体的sars疫苗 |
| EP2415783B1 (en) | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
| WO2009117030A2 (en) * | 2007-12-19 | 2009-09-24 | Macrogenics, Inc. | Improved compositions for the prevention and treatment of smallpox |
| FI20115914L (fi) | 2011-09-16 | 2013-03-17 | Oncos Therapeutics Ltd | Muunnettu onkolyyttinen virus |
| WO2014160475A1 (en) | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| CA2909225C (en) | 2013-04-10 | 2019-06-18 | Tot Shanghai R&D Center Co., Ltd. | Mutant vaccinia virus strains, uses thereof and method of producing the same |
| EP3045181B1 (en) | 2015-01-19 | 2018-11-14 | Ludwig-Maximilians-Universität München | A novel vaccine against the middle east respiratory syndrome coronavirus (MERS-CoV) |
| HK1248588A1 (zh) | 2015-08-11 | 2018-10-19 | Calidi Biotherapeutics, Inc. | 用於癌症治疗中的天花疫苗 |
| JP2019528753A (ja) | 2016-09-21 | 2019-10-17 | スティーブン エイチ． ソーン， | 高移動度グループｂｏｘｉ突然変異体 |
| IL319942A (en) | 2016-11-02 | 2025-05-01 | Evans David | Synthetic chimeric poxviruses, methods for their production, compositions containing them and uses thereof |
| ES2702618B2 (es) | 2017-09-04 | 2019-10-31 | Inst De Salud Carlos Iii | Producto de combinación que comprende una célula madre mesenquimatosa modificada y una sustancia antigénica. |
| CA3099330A1 (en) | 2018-05-02 | 2019-11-07 | Tonix Pharma Holdings Limited | Synthetic chimeric vaccinia virus |
| US20210236619A1 (en) | 2018-05-02 | 2021-08-05 | Tonix Pharma Holdings Limited | Stem cells comprising synthetic chimeric vaccinia virus and methods of using them |
-
2017
- 2017-11-02 IL IL319942A patent/IL319942A/en unknown
- 2017-11-02 TW TW106137976A patent/TWI887191B/zh active
- 2017-11-02 AU AU2017353868A patent/AU2017353868C1/en active Active
- 2017-11-02 JP JP2019545700A patent/JP2019535311A/ja active Pending
- 2017-11-02 WO PCT/US2017/059782 patent/WO2018085582A1/en not_active Ceased
- 2017-11-02 CN CN201780078546.0A patent/CN110431228B/zh active Active
- 2017-11-02 IL IL266399A patent/IL266399B2/en unknown
- 2017-11-02 MX MX2019005102A patent/MX2019005102A/es unknown
- 2017-11-02 US US15/802,189 patent/US11345896B2/en active Active
- 2017-11-02 TW TW113144133A patent/TW202528334A/zh unknown
- 2017-11-02 CA CA3042694A patent/CA3042694A1/en active Pending
- 2017-11-02 SG SG11201903893PA patent/SG11201903893PA/en unknown
- 2017-11-02 EP EP17868045.0A patent/EP3535389A4/en active Pending
-
2019
- 2019-05-07 ZA ZA2019/02868A patent/ZA201902868B/en unknown
-
2022
- 2022-05-06 ZA ZA2022/04981A patent/ZA202204981B/en unknown
- 2022-05-27 US US17/827,320 patent/US12365879B2/en active Active
- 2022-09-02 JP JP2022140113A patent/JP2022164900A/ja not_active Withdrawn
-
2024
- 2024-02-15 AU AU2024200997A patent/AU2024200997A1/en not_active Abandoned
- 2024-05-02 ZA ZA2024/03393A patent/ZA202403393B/en unknown
- 2024-06-10 JP JP2024093677A patent/JP2024107257A/ja active Pending
-
2025
- 2025-06-25 US US19/249,853 patent/US20260022350A1/en active Pending
- 2025-06-25 US US19/249,868 patent/US20260139233A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522784A5 (enExample) | ||
| CA2786333C (en) | Vaccinia virus mutants containing the major genomic deletions of mva | |
| JP7050044B2 (ja) | ポックスウイルスベクターを用いて増強された免疫応答を誘導するための組成物及び方法ベクター | |
| Cottingham et al. | Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA) | |
| Morikawa et al. | An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection | |
| JP2023515582A5 (enExample) | ||
| JP2014207903A5 (enExample) | ||
| JP2010259446A5 (enExample) | ||
| Meisinger-Henschel et al. | Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice | |
| RU2019112725A (ru) | Композиции и способы для повышения стабильности трансгенов в поксвирусах | |
| CA3042694A1 (en) | Synthetic chimeric poxviruses | |
| Zhang et al. | Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain | |
| JP2024535145A (ja) | 改変ワクシニアウイルスアンカラ（ｍｖａ）による細胞傷害性導入遺伝子発現を下方調節するためのマイクロｒｎａの利用 | |
| Zhu et al. | The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes | |
| CA2372709C (en) | Vector for integration of heterologous sequences into poxviral genomes | |
| CN1723285A (zh) | 重组的mva及其产生方法 | |
| JP2021522789A5 (enExample) | ||
| Wang et al. | Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain | |
| JP7034818B2 (ja) | 増殖性ヘルパーワクシニアウイルスを使用するポックスウイルスの製造方法 | |
| Tscharke et al. | Notes on transient host range selection for engineering vaccinia virus strain MVA | |
| NZ752893B2 (en) | Synthetic chimeric poxviruses | |
| WO2016062226A1 (zh) | 复制型痘苗病毒载体艾滋病疫苗 | |
| CA2929600C (en) | Compositions and methods vectors for inducing an enhanced immune response using poxvirus vectors | |
| Skinner et al. | Recombinant Avipoxviruses | |
| Spencer | Matthew G. Cottingham, Rikke F. Andersen, Alexandra J. Spencer, Saroj Saurya, Julie Furze, Adrian VS Hill and Sarah C. Gilbert |